Top compounds associated with response to C18orf25

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.2	1e-08
mRNA	navitoclax:PLX-4032 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.19	1e-07
mRNA	ABT-737	CTRPv2	pan-cancer	AAC	0.18	6e-07
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.18	8e-07
mRNA	ABT-263	CTRPv2	pan-cancer	AAC	0.17	9e-07
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.18	9e-07
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.17	1e-06
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	3e-06
mRNA	navitoclax:MST-312 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.16	1e-05
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.14	1e-05

Download CSV